【レポートの概要（一部）】
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Parent market
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2019
• Market size and forecast 2019-2024
• Market Outlook
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY APPLICATION
• Market segmentation by application
• Comparison by application
• Infectious diseases – Market size and forecast 2019-2024
• Cancer – Market size and forecast 2019-2024
• Other diseases – Market size and forecast 2019-2024
• Market opportunity by application
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2019-2024
• Europe – Market size and forecast 2019-2024
• Asia – Market size and forecast 2019-2024
• ROW – Market size and forecast 2019-2024
• Key leading countries
• Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
• Increase in R&D of novel vaccine adjuvants
• Development of nanoparticle adjuvants
• Rising number of collaborations
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Agenus Inc.
• Avanti Polar Lipids Inc.
• Croda International Plc
• CSL Ltd.
• GlaxoSmithKline Plc
• InvivoGen
• Merck KGaA
• OZ Biosciences SAS
• SEPPIC SA
• Vaxine Pty Ltd.
PART 14: APPENDIX
• Research methodology
• List of abbreviations
• Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO
Exhibit 01: Vendor key offerings
Exhibit 02: Global pharmaceuticals market
Exhibit 03: Segments of global pharmaceuticals market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2019
Exhibit 18: Application – Market share 2019-2024 (%)
Exhibit 19: Comparison by application
Exhibit 20: Infectious diseases – Market size and forecast 2019-2024 ($ millions)
Exhibit 21: Infectious diseases – Year-over-year growth 2020-2024 (%)
Exhibit 22: Cancer – Market size and forecast 2019-2024 ($ millions)
Exhibit 23: Cancer – Year-over-year growth 2020-2024 (%)
Exhibit 24: Other diseases – Market size and forecast 2019-2024 ($ millions)
Exhibit 25: Other diseases – Year-over-year growth 2020-2024 (%)
Exhibit 26: Market opportunity by application
Exhibit 27: Customer landscape
Exhibit 28: Market share by geography 2019-2024 (%)
Exhibit 29: Geographic comparison
Exhibit 30: North America – Market size and forecast 2019-2024 ($ millions)
Exhibit 31: North America – Year-over-year growth 2020-2024 (%)
Exhibit 32: Top 3 countries in North America
Exhibit 33: Europe – Market size and forecast 2019-2024 ($ millions)
Exhibit 34: Europe – Year-over-year growth 2020-2024 (%)
Exhibit 35: Top 3 countries in Europe
Exhibit 36: Asia – Market size and forecast 2019-2024 ($ millions)
Exhibit 37: Asia – Year-over-year growth 2020-2024 (%)
Exhibit 38: Top 3 countries in Asia
Exhibit 39: ROW – Market size and forecast 2019-2024 ($ millions)
Exhibit 40: ROW – Year-over-year growth 2020-2024 (%)
Exhibit 41: Top 3 countries in ROW
Exhibit 42: Key leading countries
Exhibit 43: Market opportunity
Exhibit 44: Impact of drivers and challenges
Exhibit 45: Vendor landscape
Exhibit 46: Landscape disruption
Exhibit 47: Vendors covered
Exhibit 48: Vendor classification
Exhibit 49: Market positioning of vendors
Exhibit 50: Agenus Inc. – Vendor overview
Exhibit 51: Agenus Inc. – Business segments
Exhibit 52: Agenus Inc. – Organizational developments
Exhibit 53: Agenus Inc. – Geographic focus
Exhibit 54: Agenus Inc. – Key offerings
Exhibit 55: Agenus Inc. – Key customers
Exhibit 56: Avanti Polar Lipids Inc. – Vendor overview
Exhibit 57: Avanti Polar Lipids Inc. – Business segments
Exhibit 58: Avanti Polar Lipids Inc. – Organizational developments
Exhibit 59: Avanti Polar Lipids Inc. – Key offerings
Exhibit 60: Avanti Polar Lipids Inc. – Key customers
Exhibit 61: Croda International Plc – Vendor overview
Exhibit 62: Croda International Plc – Business segments
Exhibit 63: Croda International Plc – Organizational developments
Exhibit 64: Croda International Plc – Geographic focus
Exhibit 65: Croda International Plc – Segment focus
Exhibit 66: Croda International Plc – Key offerings
Exhibit 67: Croda International Plc – Key customers
Exhibit 68: CSL Ltd. – Vendor overview
Exhibit 69: CSL Ltd. – Business segments
Exhibit 70: CSL Ltd. – Organizational developments
Exhibit 71: CSL Ltd. – Geographic focus
Exhibit 72: CSL Ltd. – Segment focus
Exhibit 73: CSL Ltd. – Key offerings
Exhibit 74: CSL Ltd. – Key customers
Exhibit 75: GlaxoSmithKline Plc – Vendor overview
Exhibit 76: GlaxoSmithKline Plc – Business segments
Exhibit 77: GlaxoSmithKline Plc – Organizational developments
Exhibit 78: GlaxoSmithKline Plc – Geographic focus
Exhibit 79: GlaxoSmithKline Plc – Segment focus
Exhibit 80: GlaxoSmithKline Plc – Key offerings
Exhibit 81: GlaxoSmithKline Plc – Key customers
Exhibit 82: InvivoGen – Vendor overview
Exhibit 83: InvivoGen – Product segments
Exhibit 84: InvivoGen – Key offerings
Exhibit 85: InvivoGen – Key customers
Exhibit 86: Merck KGaA – Vendor overview
Exhibit 87: Merck KGaA – Business segments
Exhibit 88: Merck KGaA – Organizational developments
Exhibit 89: Merck KGaA – Geographic focus
Exhibit 90: Merck KGaA – Segment focus
Exhibit 91: Merck KGaA – Key offerings
Exhibit 92: Merck KGaA – Key customers
Exhibit 93: OZ Biosciences SAS – Vendor overview
Exhibit 94: OZ Biosciences SAS – Product segments
Exhibit 95: OZ Biosciences SAS – Key offerings
Exhibit 96: OZ Biosciences SAS – Key customers
Exhibit 97: SEPPIC SA – Vendor overview
Exhibit 98: SEPPIC SA – Product segments
Exhibit 99: SEPPIC SA – Organizational developments
Exhibit 100: SEPPIC SA – Key offerings
Exhibit 101: SEPPIC SA – Key customers
Exhibit 102: Vaxine Pty Ltd. – Vendor overview
Exhibit 103: Vaxine Pty Ltd. – Business segments
Exhibit 104: Vaxine Pty Ltd. – Key offerings
Exhibit 105: Vaxine Pty Ltd. – Key customers
Exhibit 106: Validation techniques employed for market sizing
Exhibit 107: Definition of market positioning of vendors
【レポート販売概要】
■ タイトル：世界のワクチンアジュバント市場：用途別、地域別■ 英文：Vaccine Adjuvants Market by Application and Geography - Forecast and Analysis 2020-2024
■ 発行日：2019年11月19日
■ 調査会社：Technavio
■ 商品コード：IRTNTR40163
■ 調査対象地域：グローバル
- BOM（部品表）ソフトウェアの世界市場2016-2020About the Bill of Materials (BOM) Software Market The BOM is a list of raw materials, parts, and components and the quantity of them required to manufacture a product. There are three types of BOM: • Manufacturing BOM: It is a list of parts required to manufacture a complete product. • Engineering BOM: It is a list of parts required as per the engineering drawing notes, which are made prior to man …
- SIPトランキングの世界市場2017-2021About Session Initiation Protocol TrunkingSession Initiation Protocol (SIP) trunking is an Internet-based service that permits Voice over Internet Protocol (VoIP) users to stay connected in local and long-distance calls to and from endpoints in the traditional phone network. Technavio’s analysts forecast the global session initiation protocol trunking market to grow at a CAGR of 18.23% during the …
- 原発性胆汁性肝硬変(Primary Biliary Cirrhosis)の治療薬パイプライン動向（2015年上半期版）Primary Biliary Cirrhosis - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Primary Biliary Cirrhosis - Pipeline Review, H1 2015’, provides an overview of the Primary Biliary Cirrhosis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Primary Biliary Cirrhosis, complete with comparative analysis at various stages, therapeutics asse …
- デジタル治療の世界市場分析：用途別（糖尿病、肥満、CVD、CNS障害、呼吸器疾患、禁煙）、エンドユーザー別（患者、プロバイダー、支払者、雇用者）、地域別、動向の分析 2014-2025The global digital therapeutics market is expected to reach USD 9.3 billion by 2025, according to a new report by Grand View Research, Inc. Digital therapeutics, known as software-as-a-drug, has undergone significant developments, because of its cost-effectiveness and the potential to influence human behavior - a challenge that is difficult to overcome in healthcare. A shifting technological lands …
- 非熱的殺菌の世界市場予測（～2023年）“The non-thermal pasteurization market is projected to grow at a CAGR of 19.8%”The non-thermal pasteurization market is estimated at USD 1.1 billion in 2018 and is projected to grow at a CAGR of 19.8%, to reach USD 2.7 billion by 2023. Non-thermal pasteurization technologies have been proven to reduce food processing time and energy consumption as compared to traditional thermal technologies. This …
- ブドウ膜炎：グローバル臨床試験レビューH2, 2013Uveitis Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Uveitis Global Clinical Trials Review, H2, 2013" provides data on the Uveitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Uveitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conductio …
- 世界の血液検査・フローサイトメトリー市場Complete report $34,200. DataPack (test volumes, sales forecasts, supplier shares) $21,100. “New Frontiers in Hematology and Flow Cytometry: Global Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group’s new seven-country report designed to help current suppliers and potential market entrants identify and evaluate business opportunities em …
- 再生可能エネルギーによる分散型発電(RDEG)技術のグローバル市場（2014-2018）About Renewable Distributed Energy Generation Technologies Renewable distributed energy generation includes small-scale renewable generation technologies such as solar PV, small wind, waste to energy, stationary fuel cell, micro CHP, and micro hydro. The capacity of these distributed renewable plants is very low compared to higher capacity renewable plants. Also, distributed solar PV capacity may …
- スマート照明のグローバル市場動向（2014-2020）The smart lighting technology lead to reduction in the energy level to a greater extent by automatically turning off lights when not needed. This contributes in reducing the overall energy consumption. The smart lighting market is growing at a tremendous rate. It provides a variety of lighting control solutions to reduce the energy consumption in commercial, industrial as well as, residential sect …
- 液体窒素の世界市場予測（～2020）MarketsandMarkets projects that the liquid nitrogen market size will grow from USD 12.48 Billion in 2015 to USD 16.14 Billion by 2020, at an estimated CAGR of 5.28%. The increasing demand in various applications such as metal fabrication, electronics, healthcare, automotive, and lighting are the major factors driving the growth of the liquid nitrogen industry. Additionally, with rapid urbanization …
- 世界の位置情報基盤検索・広告市場：Global Location-based Search and Advertising Market 2014-2018TechNavio's analysts forecast the Global Location-based Search and Advertising market to grow at a CAGR of 44.75 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing use of location-based application-enabled mobile media. The Global Location-based Search and Advertising market has also been witnessing the increasing adoption of location-bas …
- 世界における末梢ガイドワイヤーの製品パイプライン動向2015Peripheral Guidewires - Pipeline Review, 2015 Summary GlobalData's Medical Devices sector report, “Peripheral Guidewires - Pipeline Review, 2015" provides an overview of Peripheral Guidewires currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players …
- ベータグルカンの世界市場予測（～2022）The beta-glucan market is projected to grow at a CAGR of 7.57% from 2017, to reach USD 476.5 Million by 2022. The market has become more diversified in recent years. The demand for food & beverages and pharmaceuticals is increasing, which is positively driving the demand for beta-glucan due to its health-promoting and prebiotic properties. With the increasing consciousness and concern about health …
- 世界の肝炎検査市場The report presents a detailed analysis of the Hepatitis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, …
- 世界のパイプライン・インフラ安全に関する市場動向（技術進歩、予測、分析：2013-2018）Pipeline safety market report focuses on the security technologies and solutions deployed across pipeline infrastructures (such as pipelines, control units, compressor stations and storage units) to protect them from leakages, physical and cyber attacks. The report is broadly segmented by solutions and technologies such as leakage detection solutions, surveillance solutions, pipeline integrity man …
